Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202868011 | Oxytetracycline hydrochlorid + phenazopyridine hydrochlorid + sulfamethizole 0ns/50mg/250mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215702018 | Oxytetracycline hydrochlorid + phenazopyridine hydrochlorid + sulfamethizole 0ns/50mg/250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478891013 | Oxytetracycline hydrochlorid+phenazopyridine hydrochlorid+sulfamethizole 0ns/50mg/250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2463845017 | Oxytetracycline hydrochlorid + phenazopyridine hydrochlorid + sulfamethizole 250mg/50mg/250mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2470319017 | Oxytetracycline hydrochlorid+phenazopyridine hydrochlorid+sulfamethizole 250mg/50mg/250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2529263010 | Oxytetracycline hydrochloride + phenazopyridine hydrochloride + sulfamethizole 250mg/50mg/250mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2532642014 | Oxytetracycline hydrochloride+phenazopyridine hydrochloride+sulfamethizole 250mg/50mg/250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2769617014 | Oxytetracycline hydrochloride + phenazopyridine hydrochloride + sulfamethizole 250mg/50mg/250mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3469624015 | Oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469625019 | Product containing oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3486167017 | Product containing oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569448010 | Product containing only oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569449019 | Product containing only oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681459013 | Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3681460015 | Oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulphamethizole 250 mg oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681461016 | Oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681462011 | Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 108317001000001115 | Oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg/1 each oral capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Product containing sulfamethizole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Sulfamethizole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Product containing oxytetracycline hydrochloride and phenazopyridine hydrochloride and sulfamethizole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Oxytetracycline hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Phenazopyridine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Genitourinary agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Product containing oxytetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Sulfamethizole | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Phenazopyridine hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Phenazopyridine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Oxytetracycline hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Sulfamethizole | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Sulfamethizole | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has active ingredient | Oxytetracycline hydrochloride | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has basis of strength substance | Oxytetracycline hydrochloride | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Product containing phenazopyridine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Medicinal product containing tetracycline structure and acting as antibacterial agent (product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Sulfamethizole | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Phenazopyridine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Oxytetracycline hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Is a | Product containing only oxytetracycline and phenazopyridine and sulfamethizole in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Oxytetracycline hydrochloride | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule | Has precise active ingredient | Sulfamethizole | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR